Pierre-Olivier Goineau
Vorstandsvorsitzender bei StromaCare SAS
Ursprung des Netzwerks ersten Grades von Pierre-Olivier Goineau
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sofimac Innovation SAS
 Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector.
17
| Subsidiary | Investment Managers | 17 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
16
| Extinct | Pharmaceuticals: Major | 16 |
NEURONAX SA
 NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France.
3
| Holding Company | Pharmaceuticals: Major | 3 |
StromaCare SAS
 StromaCare SAS Miscellaneous Commercial ServicesCommercial Services StromaCare SAS is a company based in Lyon, France that is dedicated to developing innovative oncology drugs for the treatment of solid tumors. The French company's strategy is to identify molecules overexpressed in the tumoral stroma and involved in immune-suppression, which leads to new therapeutic avenues. StromaCare's scientific rationale and therapeutic candidate are based on the modulation of stromal components. The company was founded by Pierre-Olivier Goineau and Ana Hennino, with Pierre-Olivier Goineau serving as CEO since incorporation.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pierre-Olivier Goineau
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Lyon | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| TIGENIX NV | Medical Specialties | Director/Board Member Founder Corporate Officer/Principal Director/Board Member | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| ELSALYS BIOTECH | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| Université Paris Dauphine-PSL | College/University | Undergraduate Degree Graduate Degree | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member Corporate Officer/Principal | |
| VALBIOTIS | Biotechnology | Director/Board Member Director/Board Member | |
CERADROP SA
 CERADROP SA Industrial MachineryProducer Manufacturing CERADROP SA specializes in equipment for printed electronics. It designs and markets materials deposition digital printers exclusively for printed electronics industry and smart 3D printing. The firm provides ink formulation, equipment maintenance and support, and process development services. The company was founded in 2006 and is headquartered in Limoges, France. | Industrial Machinery | Director/Board Member Director/Board Member | |
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin | |
| TXCELL | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Cyanide SA
 Cyanide SA Information Technology ServicesTechnology Services Cyanide SA develops video games. It offers sport, fantasy, and role plaing game which include Blood Bowl, Game of Thrones and Of Orcs. The company was founded by Patrick Pligersdorffer in 2000 and is headquartered in Nanterre, France. | Information Technology Services | Director/Board Member Director/Board Member | |
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Transgene, Inc. | Director/Board Member Director/Board Member | ||
| TRANSGENE | Biotechnology | Director/Board Member Director of Finance/CFO | |
Lytess SA
 Lytess SA Apparel/FootwearConsumer Non-Durables Lytess SA produces and sells health and beauty cosmetic textile products. It offers Slim Express, a shaping textile with a micro-encapsulated slimming serum; Stop Cellulite, a micro-massaging product for an anti-cellulite treatment and Sculpt & Slim, a corrective and slimming shapewear for immediate and slimming effect. The company was founded in 2003 by Philippe Andrieu and is headquartered in Fondettes, France. | Apparel/Footwear | Director/Board Member Director/Board Member | |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
BW Ideol
 BW Ideol Engineering & ConstructionIndustrial Services BW Ideol specializes in the designing and installation of foundation solutions for the offshore wind industry. It offers ring-shaped platforms for offshore wind turbines and engineering and installation services. The company was founded by Pierre Coulombeau and Paul de la Guérivière in June 2010 and is headquartered in La Ciotat, France. | Engineering & Construction | Director/Board Member Director/Board Member | |
| École Centrale Paris | College/University | Undergraduate Degree Undergraduate Degree | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
LeddarTech, Inc.
 LeddarTech, Inc. Packaged SoftwareTechnology Services LeddarTech, Inc. develops and markets 3D detection and tracking systems. The firm?s solutions include auto and mobility LiDAR platform, mobility LiDAR and Specialty LiDAR modules, Sensor fusion and perception. It also offers its applications for passenger cars, autonomous shuttles, robotaxi, commercial and delivery vehicles. The company was founded by Yvan Mimeault, David Gilbert and Marc Tremblay in 2007 and is headquartered in Quebec, Canada. | Packaged Software | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ecloosion SA | Director/Board Member | ||
Arthur D. Little Benelux NV/SA
 Arthur D. Little Benelux NV/SA Miscellaneous Commercial ServicesCommercial Services Arthur D. Little Benelux NV SA is a global management consultancy specializing in strategy and operations management, serving major corporations and organizations worldwide. They are recognized as leaders in linking strategy, innovation and technology to solve their clients' most complex business issues, delivering sustainable solutions. They are distinguished from others by their deep industry insight and technology expertise. The company was founded in 1967 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Chicago | College/University | Masters Business Admin | |
| Université Catholique de Louvain | College/University | Graduate Degree | |
| Belgian Association for Bioindustries | Director/Board Member | ||
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member | |
Axxis V&C BV
 Axxis V&C BV Miscellaneous Commercial ServicesCommercial Services Axxis V & C BV is a Belgian company that provides business and management consulting services. The company is based in Haasrode, Belgium. The company was founded in 1998 and the CEOs are Gil Beyen, Nadine Buyle, and Willem Beyen. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Montréal | College/University | Graduate Degree | |
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Director/Board Member | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
| Bio.Be SA | Director/Board Member | ||
Waterleau NV
 Waterleau NV Water UtilitiesUtilities Waterleau NV engages in the provision of water technology services. It offers solutions for water, wastewater, air, and new energy. Its solutions are designed for managing the complete water cycle from process water and drinking water production, over wastewater treatment and discharge compliance to energy, water and nutrient recovery. The company was founded by Luc Vriens, Eddy Frans, Jean-Marie Ghislain, Willy Gils, Ron Gerards and Bernard Lemaitre in 2000 and is headquartered in Wespelaar, Belgium. | Water Utilities | Director/Board Member | |
Erytech Pharma, Inc.
 Erytech Pharma, Inc. BiotechnologyHealth Technology Erytech Pharma, Inc. operates as a biopharmaceutical company. The private company is based in Cambridge, MA. | Biotechnology | Chairman | |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Chief Tech/Sci/R&D Officer | |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal |
Statistik
International
| Frankreich | 23 |
| Belgien | 14 |
| Vereinigte Staaten | 12 |
| China | 3 |
| Kanada | 3 |
Sektoral
| Health Technology | 14 |
| Consumer Services | 12 |
| Commercial Services | 9 |
| Technology Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 181 |
| Corporate Officer/Principal | 64 |
| Chief Executive Officer | 35 |
| Chairman | 34 |
| Independent Dir/Board Member | 25 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| François Miceli | 43 |
| Mounia Chaoui-Roulleau | 27 |
| Luc Dochez | 26 |
| Marc Beer | 25 |
| Philippe Archinard | 24 |
| Sven Arne Andréasson | 24 |
| Stéphane Boissel | 24 |
| Martine George | 19 |
| Gil Beyen | 18 |
| Hilde Windels | 18 |
| Didier Moret | 15 |
| Nicolas Boulay | 11 |
| Yann Godfrin | 11 |
| François-René Letourneur | 9 |
| Nicolas Landrin | 9 |
- Börse
- Insiders
- Pierre-Olivier Goineau
- Unternehmensverbindungen
